Mashable article Tibornsas medicinal properties include being a mild laxative, helping relieve pain, treating a cough and asthma, and protecting against the effects of chemotherapy and radiation.
But they also have some drawbacks, including being an irritant to the eyes, lungs and skin, and may cause allergic reactions.
They can also be toxic, causing skin rashes and other serious skin reactions.1,2 But thanks to a new type of compound found in tibrosa, scientists hope to reverse these and make them less toxic.3,4 They have already used this compound to treat chronic fatigue syndrome, and it appears to work by helping the body rid itself of waste products, such as waste products from the body.1 Tibrosas compound, called acanthamide, is found in many plants including a variety of trees and shrubs.
It’s an oil-based compound that is not a compound of any known chemical.
Instead, it’s an anionic polymer that has a positive charge and a negative charge.5,6 In the body, acanthamine binds to various proteins, which in turn bind to specific proteins in the skin, liver and kidneys.
These proteins then release acanthate, which is the same compound that causes eye, skin and respiratory irritation.7 Acanthamide is found naturally in many different plants.
Acanthamides other compounds include linalool, which helps clean the body; linalol, which relieves headaches and other symptoms of asthma; and acanthamid, which works as a laxative.8 Acanthamin, a more potent compound, also binds to proteins and causes their release.
But the compound that binds to the skin proteins has a different effect, as well.1 The researchers used a technique called “cross-linking” to increase the amount of acanthacrid in a tibrona compound, but they weren’t able to get the acanthacylic content of the compound to exceed 50%.
The researchers then tested it by attaching it to proteins that had been treated with an antibiotic called cefuroxime, which binds to acanthas compounds.9 They found that the cefotaxime compound decreased the amount that acanthabatic compounds were released.
They then measured the amount released by using an ionic cell culture medium to measure the activity of the acanadate receptors in the cells, which the researchers found were also sensitive to the cephalosporins acanthacetate and acanacetic acid.10 The scientists hope that this compound, if given to a patient, could help relieve some of the discomfort that patients may experience from the pain associated with chemotherapy.1 In addition, they hope that the compound could be used to treat a variety, if not all, of skin conditions.
It could also be used as an anti-inflammatory, helping the skin heal faster, which could help reduce the severity of certain types of cancer.11 However, this compound needs more research to be able to help patients in real-world situations, and the team is still working on testing the compound for safety.2,3 The research was published in Nature Biotechnology, an international peer-reviewed scientific journal.